EUVIMEDEUVIMED entdecken
Crossref

Non-invasive diagnosis of bronchial asthma and chronic obstructive pulmonary disease by exhaled breath analysis: potential of proton mass spectrometry

M. K. Mustafina, A. S. Silantyev, P. Y. Kopylov

Perm Medical Journal · 07.11.2026 · 43 (5) · 101-112

DOI: 10.17816/pmj435101-112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Perm Medical Journal, online erschienen am 07.11.2026. Verfasst von M. K. Mustafina und 2 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To identify specific volatile organic compound (VOC) profiles in exhaled breath of patients with bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) using proton-transfer-reaction time-of-flight mass spectrometry (PTR-TOF-MS), and to evaluate the potential of machine learning for the diagnosis and differential diagnosis of these diseases. Materials and methods. A single-center observational cross-sectional study was conducted. The study included 95 patients with BA, 95 patients with COPD, and 110 age- and sex-matched healthy volunteers. In addition to standard clinical and instrumental examinations, all participants underwent real-time exhaled breath analysis using PTR-TOF-MS. The XGBoost gradient boosting algorithm was applied to identify diagnostically significant VOCs. The diagnostic performance of the models was assessed by the area under the receiver operating characteristic (ROC) curve (AUC), sensitivity, and specificity.

Results

The most significant predictors for the diagnosis of BA and COPD were compounds with m/z 71.055 (2-pentanone) and m/z 79.054 (benzene), with their maximum concentration observed in patients with COPD (p 0.001). The diagnostic model for BA demonstrated an AUC of 0.710, with a sensitivity of 65.9 % and a specificity of 72.6 %. For COPD, the model showed higher diagnostic accuracy: AUC 0.821, sensitivity 55.6 %, and specificity 86.0 %. In a direct comparison of VOC profiles between BA and COPD, the diagnostic model achieved an AUC of 0.806, with a sensitivity of 65.6 % and a specificity of 87.0 %.

Conclusions

PTR-TOF-MS analysis of exhaled breath enables the identification of specific metabolic profiles in patients with BA and COPD and provides the possibility for their non-invasive diagnosis and differential diagnosis. Further multicenter studies and external validation of the developed models are required to confirm these findings.

Zitieren

APA

Mustafina, M. K., Silantyev, A. S., & Kopylov, P. Y. (2026). Non-invasive diagnosis of bronchial asthma and chronic obstructive pulmonary disease by exhaled breath analysis: potential of proton mass spectrometry. Perm Medical Journal, 43(5), 101-112. https://doi.org/10.17816/pmj435101-112

Vancouver

Mustafina MK, Silantyev AS, Kopylov PY. Non-invasive diagnosis of bronchial asthma and chronic obstructive pulmonary disease by exhaled breath analysis: potential of proton mass spectrometry. Perm Medical Journal. 2026;43(5):101-112. doi:10.17816/pmj435101-112

BibTeX
@article{Mustafina2026,
  author = {Mustafina, M. K. and Silantyev, A. S. and Kopylov, P. Y.},
  title = {Non-invasive diagnosis of bronchial asthma and chronic obstructive pulmonary disease by exhaled breath analysis: potential of proton mass spectrometry},
  journal = {Perm Medical Journal},
  year = {2026},
  volume = {43},
  number = {5},
  pages = {101--112},
  doi = {10.17816/pmj435101-112}
}
Kostenlos starten →